Price $79.61 |
Market Cap
109.44B
|
Sector Health Care |
Div. Growth
8.10%
|
|
P/E
27.4
|
P/B
2.16
|
P/S
3.61
|
Dividend %
3.30%
|
|
P/CF
106.9
|
P/FCF
183.6
|
Op. Cash Flow
5.64M
|
FCF
0.4
|
|
Op. Margin
18.00%
|
Net Margin
13.20%
|
ROE
7.80%
|
ROI
6.90%
|
|
ROA
4.40%
|
EPS Growth
-16.50%
|
Current Ratio
1.9
|
Debt/Equity
38.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Interpace Biosciences Inc (IDXG) | $0.82 | - | - | 5.1M | Strong Buy |
| LifeVantage Corp (LFVN) | $3.45 | - | 3.10% | 48.7M | Strong Buy |
| PetIQ Inc (PETQ) | $11.60 | - | - | 315.7M | Strong Buy |
| Dare Bioscience Inc (DARE) | $0.97 | - | - | 95M | Strong Buy |
| Precision BioSciences Inc (DTIL) | $0.83 | - | - | 126.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
